Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
He is the mole in the RXMD world! LOL!
Wellllllllllllllllllllllllllllllll.........................................................
It was at the end of day Thursday.
Summer? Weather Channel says it's over. I'm getting my snowsuit on and the snowblower ready!
That should drive a LOT of buying. Nothing like better "official" news!
We can't let MM's take this down with 10,000 trades.....one day we will crush them!
Been longer for a lot of longs here!
RXMD is on the most active, most posted, and most read boards still! We need more newbies!
Up 45% today prediction?
Crown Royal, Melatonin, and Lavender. LOL...not mixed together though.
Turbo - We are looking good. Confidence is very high now!
I also wouldn't consider a $25,000 buy a paint job. That's a serious buy and money I wish I had!
Someone had a spare $25,000 laying around at 3:58pm today......lol!
This should close green.........we shall see.
A trend I've noticed over the years is that lots of buyers show up during the last 10 minutes.
This caught MM's off guard and they are driving down the price now that the volume is low again..also shorts.
In due time, this is a huge turning point for us here....
THIS NEWS NEEDS TO BE POSTED EVERYWHERE!!!!!
I think we go over that today.....
I agree there is much more to this BIG picture.....we will find out soon enough. I'm glad I've added the past few months here and there.
I believe so, but I don't know how this plays out now with the news today....
CLOSED OVER 40%%%%%
WELCOME ALL NEW RXMD INVESTORS!!!!!!!!!!!!!!!
These 10,000 trades at the final bell make me laugh. MM's can't hold us down now that we have a LOT of fresh eyes on this stock...
I believe this won't be the last news PR we get in the next few days.....something else should be coming soon hopefully!
Agree. We hopefully have fresh new investors today and going forward....
Give it a few more days.....we know the word needs to spread to their shareholders also.....this will only get better and I'm happy to see this news!
$RXMD - WE ARE BACK!!!! $RXMD - HUGE RESTRUCTURING NEWS - Progressive Care Enters into an Agreement with NextPlat for Significant Strategic Investment and Debt Restructuring
BY GlobeNewswire
— 1:31 PM ET 08/31/2022
MIAMI, FL, Aug. 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that it has entered into an agreement for a recapitalization of its current debt and a strategic investment by NextPlat Corp. (“NextPlat”).
Under the agreement, Progressive Care (RXMD) will receive an aggregate of $6 million from NextPlat in exchange for the issuance to NextPlat of 3,000 units of Series B Preferred Stock as well as warrants to purchase up to 3,000 shares of Series B Preferred Stock at an exercise price of $2,000 per share. In addition, NextPlat’s Executive Chairman and CEO, Charles M. Fernandez, board member, Rodney Barreto, and certain other investors will purchase approximately $2.8 million of outstanding convertible debt in Progressive Care (RXMD) at an agreed fixed conversion price of $0.02 per share. Progressive Care (RXMD) and NextPlat agreed to reduce the interest rate on the purchased debt from 10% to 5% per annum and extend the maturity date to August 30, 2027.
NextPlat’s management team and select members of its Board of Directors will provide Progressive Care (RXMD) with their market-proven experience in healthcare and digital technology including the development of new healthcare and lifestyle products to be sold via NextPlat’s global e-commerce marketplaces. As part of this transaction, Mr. Fernandez will be appointed as Chairman of Progressive Care’s Board of Directors (the “Board”) replacing Alan Jay Weisberg who will step down from this position to assume the new role of Vice Chairman, remaining on the Board, while also continuing to serve as Progressive Care’s CEO. Mr. Barreto will also be joining the Board as Vice Chairman. Dawson James Securities Inc. (“Dawson”) served as the placement agent for this transaction. Progressive Care (RXMD) intends to utilize a portion of the growth capital to further fund the deployment of its digital platforms and the development and sale of new health, fitness, and beauty products.
Over the past 30 years, Mr. Fernandez has successfully identified profitable start-up and dislocation opportunities, and built significant shareholder value, executing both private and public exits. Mr. Fernandez’s expertise in technology and healthcare includes co-founding Lakeview Health Systems (acquired by a private equity firm for approximately $70 million) and Continucare Corporation (acquired by Metropolitan Health Networks, Inc. for approximately $400 million) where he served as chairman, president and CEO. He also served as an investor, director, and Chairman of the Audit Committee of IVAX Corporation for nearly a decade prior to its purchase by Teva Pharmaceuticals for $8.7 billion.
Charles M. Fernandez said, ”Progressive Care has built a vibrant and rapidly growing healthcare services and technology company currently serving tens of thousands of customers who rely on its PharmcoRx platform and services every day. As a technology and healthcare entrepreneur, I see tremendous value in Progressive Care’s capabilities which is why I am personally investing alongside NextPlat. I believe we can leverage our expertise, industry know-how, and global e-commerce platforms to accelerate their continued growth domestically as well as internationally. As long-term investors, we are committed to harnessing the power of digital technologies including Web3, to capitalize on the ongoing digital transformation of Progressive Care (RXMD) and the entire healthcare industry.”
Alan Jay Weisberg commented, “Progressive Care has pursued a vision of being able to transform the healthcare industry by creating data-driven tools and technology. Charlie and the team at NextPlat have extensive knowledge and experience in utilizing digital technology and we believe will help Progressive Care (RXMD) build significant value for all stakeholders including patients, payors, practitioners, and investors. We are excited to have this team of industry leaders as our new long-term investors and partners, and look forward to working together to advance our vision for modern healthcare.”
For more information about Progressive Care (RXMD), please visit the Company’s website. Connect and stay in touch with us on social media:
Progressive Care Inc. (RXMD)
Let's close at $.035 today, tomorrow $.055, and Friday $.065
$RXMD - HUGE RESTRUCTURING NEWS OUT! $RXMD - HUGE RESTRUCTURING NEWS - Progressive Care Enters into an Agreement with NextPlat for Significant Strategic Investment and Debt Restructuring
BY GlobeNewswire
— 1:31 PM ET 08/31/2022
MIAMI, FL, Aug. 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that it has entered into an agreement for a recapitalization of its current debt and a strategic investment by NextPlat Corp. (“NextPlat”).
Under the agreement, Progressive Care (RXMD) will receive an aggregate of $6 million from NextPlat in exchange for the issuance to NextPlat of 3,000 units of Series B Preferred Stock as well as warrants to purchase up to 3,000 shares of Series B Preferred Stock at an exercise price of $2,000 per share. In addition, NextPlat’s Executive Chairman and CEO, Charles M. Fernandez, board member, Rodney Barreto, and certain other investors will purchase approximately $2.8 million of outstanding convertible debt in Progressive Care (RXMD) at an agreed fixed conversion price of $0.02 per share. Progressive Care (RXMD) and NextPlat agreed to reduce the interest rate on the purchased debt from 10% to 5% per annum and extend the maturity date to August 30, 2027.
$RXMD - HUGE RESTRUCTURING NEWS - Progressive Care Enters into an Agreement with NextPlat for Significant Strategic Investment and Debt Restructuring
BY GlobeNewswire
— 1:31 PM ET 08/31/2022
MIAMI, FL, Aug. 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that it has entered into an agreement for a recapitalization of its current debt and a strategic investment by NextPlat Corp. (“NextPlat”).
Under the agreement, Progressive Care (RXMD) will receive an aggregate of $6 million from NextPlat in exchange for the issuance to NextPlat of 3,000 units of Series B Preferred Stock as well as warrants to purchase up to 3,000 shares of Series B Preferred Stock at an exercise price of $2,000 per share. In addition, NextPlat’s Executive Chairman and CEO, Charles M. Fernandez, board member, Rodney Barreto, and certain other investors will purchase approximately $2.8 million of outstanding convertible debt in Progressive Care (RXMD) at an agreed fixed conversion price of $0.02 per share. Progressive Care (RXMD) and NextPlat agreed to reduce the interest rate on the purchased debt from 10% to 5% per annum and extend the maturity date to August 30, 2027.
NextPlat’s management team and select members of its Board of Directors will provide Progressive Care (RXMD) with their market-proven experience in healthcare and digital technology including the development of new healthcare and lifestyle products to be sold via NextPlat’s global e-commerce marketplaces. As part of this transaction, Mr. Fernandez will be appointed as Chairman of Progressive Care’s Board of Directors (the “Board”) replacing Alan Jay Weisberg who will step down from this position to assume the new role of Vice Chairman, remaining on the Board, while also continuing to serve as Progressive Care’s CEO. Mr. Barreto will also be joining the Board as Vice Chairman. Dawson James Securities Inc. (“Dawson”) served as the placement agent for this transaction. Progressive Care (RXMD) intends to utilize a portion of the growth capital to further fund the deployment of its digital platforms and the development and sale of new health, fitness, and beauty products.
Over the past 30 years, Mr. Fernandez has successfully identified profitable start-up and dislocation opportunities, and built significant shareholder value, executing both private and public exits. Mr. Fernandez’s expertise in technology and healthcare includes co-founding Lakeview Health Systems (acquired by a private equity firm for approximately $70 million) and Continucare Corporation (acquired by Metropolitan Health Networks, Inc. for approximately $400 million) where he served as chairman, president and CEO. He also served as an investor, director, and Chairman of the Audit Committee of IVAX Corporation for nearly a decade prior to its purchase by Teva Pharmaceuticals for $8.7 billion.
Charles M. Fernandez said, ”Progressive Care has built a vibrant and rapidly growing healthcare services and technology company currently serving tens of thousands of customers who rely on its PharmcoRx platform and services every day. As a technology and healthcare entrepreneur, I see tremendous value in Progressive Care’s capabilities which is why I am personally investing alongside NextPlat. I believe we can leverage our expertise, industry know-how, and global e-commerce platforms to accelerate their continued growth domestically as well as internationally. As long-term investors, we are committed to harnessing the power of digital technologies including Web3, to capitalize on the ongoing digital transformation of Progressive Care (RXMD) and the entire healthcare industry.”
Alan Jay Weisberg commented, “Progressive Care has pursued a vision of being able to transform the healthcare industry by creating data-driven tools and technology. Charlie and the team at NextPlat have extensive knowledge and experience in utilizing digital technology and we believe will help Progressive Care (RXMD) build significant value for all stakeholders including patients, payors, practitioners, and investors. We are excited to have this team of industry leaders as our new long-term investors and partners, and look forward to working together to advance our vision for modern healthcare.”
For more information about Progressive Care (RXMD), please visit the Company’s website. Connect and stay in touch with us on social media:
Progressive Care Inc. (RXMD)
$RXMD - HUGE RESTRUCTURING NEWS - Progressive Care Enters into an Agreement with NextPlat for Significant Strategic Investment and Debt Restructuring
BY GlobeNewswire
— 1:31 PM ET 08/31/2022
MIAMI, FL, Aug. 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Progressive Care Inc. (RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that it has entered into an agreement for a recapitalization of its current debt and a strategic investment by NextPlat Corp. (“NextPlat”).
Under the agreement, Progressive Care (RXMD) will receive an aggregate of $6 million from NextPlat in exchange for the issuance to NextPlat of 3,000 units of Series B Preferred Stock as well as warrants to purchase up to 3,000 shares of Series B Preferred Stock at an exercise price of $2,000 per share. In addition, NextPlat’s Executive Chairman and CEO, Charles M. Fernandez, board member, Rodney Barreto, and certain other investors will purchase approximately $2.8 million of outstanding convertible debt in Progressive Care (RXMD) at an agreed fixed conversion price of $0.02 per share. Progressive Care (RXMD) and NextPlat agreed to reduce the interest rate on the purchased debt from 10% to 5% per annum and extend the maturity date to August 30, 2027.
NextPlat’s management team and select members of its Board of Directors will provide Progressive Care (RXMD) with their market-proven experience in healthcare and digital technology including the development of new healthcare and lifestyle products to be sold via NextPlat’s global e-commerce marketplaces. As part of this transaction, Mr. Fernandez will be appointed as Chairman of Progressive Care’s Board of Directors (the “Board”) replacing Alan Jay Weisberg who will step down from this position to assume the new role of Vice Chairman, remaining on the Board, while also continuing to serve as Progressive Care’s CEO. Mr. Barreto will also be joining the Board as Vice Chairman. Dawson James Securities Inc. (“Dawson”) served as the placement agent for this transaction. Progressive Care (RXMD) intends to utilize a portion of the growth capital to further fund the deployment of its digital platforms and the development and sale of new health, fitness, and beauty products.
Over the past 30 years, Mr. Fernandez has successfully identified profitable start-up and dislocation opportunities, and built significant shareholder value, executing both private and public exits. Mr. Fernandez’s expertise in technology and healthcare includes co-founding Lakeview Health Systems (acquired by a private equity firm for approximately $70 million) and Continucare Corporation (acquired by Metropolitan Health Networks, Inc. for approximately $400 million) where he served as chairman, president and CEO. He also served as an investor, director, and Chairman of the Audit Committee of IVAX Corporation for nearly a decade prior to its purchase by Teva Pharmaceuticals for $8.7 billion.
Charles M. Fernandez said, ”Progressive Care has built a vibrant and rapidly growing healthcare services and technology company currently serving tens of thousands of customers who rely on its PharmcoRx platform and services every day. As a technology and healthcare entrepreneur, I see tremendous value in Progressive Care’s capabilities which is why I am personally investing alongside NextPlat. I believe we can leverage our expertise, industry know-how, and global e-commerce platforms to accelerate their continued growth domestically as well as internationally. As long-term investors, we are committed to harnessing the power of digital technologies including Web3, to capitalize on the ongoing digital transformation of Progressive Care (RXMD) and the entire healthcare industry.”
Alan Jay Weisberg commented, “Progressive Care has pursued a vision of being able to transform the healthcare industry by creating data-driven tools and technology. Charlie and the team at NextPlat have extensive knowledge and experience in utilizing digital technology and we believe will help Progressive Care (RXMD) build significant value for all stakeholders including patients, payors, practitioners, and investors. We are excited to have this team of industry leaders as our new long-term investors and partners, and look forward to working together to advance our vision for modern healthcare.”
For more information about Progressive Care (RXMD), please visit the Company’s website. Connect and stay in touch with us on social media:
Progressive Care Inc. (RXMD)
"Mr. Fernandez will be appointed as Chairman of Progressive Care’s Board of Directors (the “Board”) replacing Alan Jay Weisberg who will step down from this position to assume the new role of Vice Chairman"
With 12 milllion volume just today and the news just starting to get out, we should see $.05 by Friday with 20 mil volume at least?
Up 43% and going up up up! $.20 or more?
We needed this!
I'd hate to sell any shares with this news now....
Agreed! This is great!